GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSL:MEDI) » Definitions » Price-to-Owner-Earnings

Medistim ASA (OSL:MEDI) Price-to-Owner-Earnings : 30.12 (As of May. 25, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA Price-to-Owner-Earnings?

As of today (2025-05-25), Medistim ASA's share price is kr206.00. Medistim ASA's Owner Earnings per Share (TTM) ended in Dec. 2024 was kr6.84. It's Price-to-Owner-Earnings for today is 30.12.


The historical rank and industry rank for Medistim ASA's Price-to-Owner-Earnings or its related term are showing as below:

OSL:MEDI' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 19.59   Med: 33.45   Max: 62.07
Current: 30.1

During the past 13 years, the highest Price-to-Owner-Earnings of Medistim ASA was 62.07. The lowest was 19.59. And the median was 33.45.


OSL:MEDI's Price-to-Owner-Earnings is ranked worse than
54.11% of 292 companies
in the Medical Devices & Instruments industry
Industry Median: 27.955 vs OSL:MEDI: 30.10

As of today (2025-05-25), Medistim ASA's share price is kr206.00. Medistim ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was kr6.71. Therefore, Medistim ASA's PE Ratio (TTM) for today is 30.70.

As of today (2025-05-25), Medistim ASA's share price is kr206.00. Medistim ASA's EPS without NRI for the trailing twelve months (TTM) ended in was kr6.71. Therefore, Medistim ASA's PE Ratio without NRI for today is 30.70.

During the past 13 years, Medistim ASA's highest PE Ratio without NRI was 82.39. The lowest was 17.75. And the median was 33.79.


Medistim ASA Price-to-Owner-Earnings Historical Data

The historical data trend for Medistim ASA's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medistim ASA Price-to-Owner-Earnings Chart

Medistim ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.62 51.01 34.34 41.06 21.84

Medistim ASA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 21.84 -

Competitive Comparison of Medistim ASA's Price-to-Owner-Earnings

For the Medical Devices subindustry, Medistim ASA's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medistim ASA's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Medistim ASA's Price-to-Owner-Earnings falls into.


;
;

Medistim ASA Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Medistim ASA's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=206.00/6.84
=30.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medistim ASA  (OSL:MEDI) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Medistim ASA Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Medistim ASA's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Medistim ASA Business Description

Traded in Other Exchanges
Address
Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.

Medistim ASA Headlines